Vanthys Pharmaceutical Development Profile
Key Indicators
- Authorised Capital ₹ 22.50 Cr
as on 20-04-2024
- Paid Up Capital ₹ 22.50 Cr
as on 20-04-2024
- Company Age 15 Year, 7 Months
- Last Filing with ROC 31 Mar 2018
- Revenue 0.03%
(FY 2018)
- Profit 8.39%
(FY 2018)
- Ebitda 5.94%
(FY 2018)
- Net Worth 6.02%
(FY 2018)
- Total Assets 4.27%
(FY 2018)
About Vanthys Pharmaceutical Development
- CIN/LLPIN
U73100UP2009PTC037333
- Company No.
037333
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 May 2009
- Date of AGM
20 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Vanthys Pharmaceutical Development?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shwetank Tiwari  | Company Secretary | 16-Jan-2018 | Current |
| Nitin Garg | CFO | 06-Feb-2017 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shyamsundar Bang | Director | 20-Sep-2018 | Current |
| Benny Thomas | Director | 28-Mar-2018 | Current |
| Saravanakumar Dhakshinamoorthy | Additional Director | 15-May-2019 | Current |
Financial Performance and Corporate Structure Insights of Vanthys Pharmaceutical Development.
Vanthys Pharmaceutical Development Private Limited, for the financial year ended 2018, experienced modest growth in revenue, with a 0.03% increase. The company also saw a slight improvement in profitability, with a 8.39% increase in profit. The company's net worth moved up by a moderate rise of 6.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vanthys Pharmaceutical Development?
In 2018, Vanthys Pharmaceutical Development had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vanthys Pharmaceutical Development?
Unlock and access historical data on people associated with Vanthys Pharmaceutical Development, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vanthys Pharmaceutical Development, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vanthys Pharmaceutical Development's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
